Skip to content

Trichotillomania: Group Cognitive-Behavioral Therapy

Group Treatment for Trichotillomania: Cognitive-Behavioral Therapy Versus Supportive Therapy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01968343
Enrollment
44
Registered
2013-10-24
Start date
2008-01-31
Completion date
Unknown
Last updated
2015-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trichotillomania

Brief summary

Objective: Trichotillomania is a psychiatric condition characterized by chronic pulling and plucking of one's own hair. Cognitive behavioral therapy shows promise as a treatment. However, there have been no randomized, controlled studies of the efficacy of group cognitive-behavioral therapy. Methods: We evaluated 44 subjects, whom met the criteria for a diagnosis of trichotillomania. Subjects were randomized to receive 22 sessions of either group cognitive-behavioral therapy or group supportive therapy (control).

Interventions

BEHAVIORALCognitive-behavioral therapy.

Subjects receive 22 sessions of cognitive-behavioral therapy.

OTHERSupportive therapy.

Subjects receive 22 sessions of supportive therapy.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients having been diagnosed with trichotillomania according to Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) criteria; being at least 18 years of age; and having had four or more years of schooling.

Exclusion criteria

* Patients that having been diagnosed with trichotillomania according to DSM-IV criteria; having less of 18 years of age; and having less of four years of schooling. * Patients with a history of suicidal ideation, * Patients with any clinical pathology requiring emergency treatment at admission, * Patients with mental retardation or any other central nervous system disorder that severely impairs cognitive function, * those with a psychotic disorder, * those currently being treated with psychotropic drugs, * those with any DSM-IV axis II diagnosis, * those who scored ≤ 2 on the MGH-HPS in an initial screening.

Design outcomes

Primary

MeasureTime frameDescription
Massachusetts General Hospital (MGH) Hairpulling Scale (HPS)22 weeksThe MGH-HPS comprises seven self-report items that are scored on a Likert scale (0-4 points).22 Higher MGH-HPS scores correspond to greater severity of trichotillomania symptoms. Reference: Psychotherapy and Psychosomatic Journal 1995;64:141-5

Secondary

MeasureTime frameDescription
Beck Depression Inventory (BDI)22 weeksThe BDI consists of 21 items, scored from 0 to 3, higher scores corresponding to greater severity of depression. It is a self-report measure of depression that is widely used in research and in clinical practice. Reference: Archives of General Psychiatry 1961;4:53-63.

Other

MeasureTime frameDescription
Social Adjustment Scale (SAS) Self-Report (SR)22 weeksThe SAS-SR is a self-report scale consisting of 54 questions addressing seven specific areas in relation to the last two weeks25: work; social life and leisure; family relationships; marital relationship; relationships with children; home life; and financial status, each corresponding to a partial score. Reference: Archives of General Psychiatry 1976;33:111-5.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026